RecruitingNCT06519162

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

Exploration of Liver-gut Axis Through Identification of Liver Disease-specific Microbiome

Sponsor

Chungnam National University Hospital

Enrollment

3,000 participants

Start Date

Jul 8, 2024

Study Type

OBSERVATIONAL

Conditions

Non-Alcoholic Fatty Liver Disease Autoimmune Hepatitis Primary Sclerosing Cholangitis Primary Biliary Cirrhosis Liver Abscess

Summary

In this study, we aim to identify gut microbiomes specific to patients with chronic refractory liver disease and to conduct a gut-liver axis study on the pathogenesis and disease progression.

Eligibility

Min Age: 19 Years

Inclusion Criteria3

Adults aged 19 years and older diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, who have consented to participate in this study at Chungnam National University Hospital.
Adults aged 19 years and older, who are cohabitants of patients diagnosed with autoimmune hepatitis, primary biliary cholangitis, primary sclerosing cholangitis, non-alcoholic fatty liver disease, or liver abscess, and have consented to participate in this study at Chungnam National University Hospital.
B. Exclusion